$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Engineered cardiac tissue models come in a diverse array of geometries and configurations for recapitulating various aspects of the native cardiac niche that are difficult to attain with traditional two-dimensional cell culture. One of the most common configurations is the linear tissue strip, with flexible anchors at each end to induce tissue self-assembly and providing the tissue with a defined preload and a readout of the resulting twitch forces1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21
,22,23,24,25,26,27. The force generated can be robustly determined through the optical tracking of the tissue shortening and using elastic beam theory to calculate the force from the measured deflections and the spring constant of the anchors1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,
21,22,25,26,28.
However, cardiac tissue engineering is still an evolving field, and some challenges remain. Specialized equipment, such as custom-made bioreactors and functional assessment devices, are required for each model system10,29,30,31. The size and complexity of the microenvironment of these constructs are often limited by low throughput due to labor-intensive protocols, high numbers of cells, and tissue fragility. To address this, some groups have turned to the fabrication of microtissues containing only hundreds or thousands of cells to facilitate high-throughput assays that are useful for drug discovery. However, this reduced scale complicates the accurate assessment of function12, eliminates key aspects of the native cardiac niche (such as nutrient/oxygen diffusion gradients and complex architecture36), and limits the amount of material available for subsequent molecular and structural analysis (often requiring pooling of the tissues). Table 1 summarizes some of the configurations of linear tissue strip models in the literature1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,
21,22,23,24,25,26,37,38,39,40.
| Group | Cells per tissue | Tissues per plate | Plate format | Anchoring feature | Functional data acquisition method | Shared media bath? | Functional measure-
ment in situ? |
| Yoshida (ECT)38 | 4 million | 6 | modified 6-well plate* | force transducer | direct force measurement | no | no |
| Chan (hESC-CM-ECTs)26 | 310 k | 6 | custom 6-well dish | PDMS posts | direct force measurement | yes | no |
| Feinberg (dyn-EHT)16 | 1.5 million | 6 | custom 6-well dish | PDMS wire | tissue shape | no | yes |
| RADISIC (BioWire)39, 40 | 110 k | 8 | | polymer wire | wire shape | yes | yes |
| Costa (single hECT)1, 2 | 1-2million | 4** | 10 cm Petri dish** | PDMS posts | optical deflection (edge/object tracking) | yes | yes |
| Costa (multi-hECT)3–9 | 500 k-1 million | 6 | 6 cm Petri dish | PDMS posts | optical deflection (edge/object tracking) | yes | yes |
| Costa (multi-hECT W/ SPoT) | 1 million | 6 | 6 cm Petri dish | PDMS posts with black caps | optical deflection (object tracking) | yes | yes |
| Passier (EHT)17 | 245 k | 36 | 12-well plate | PDMS posts with black caps | optical deflection (object tracking) | yes | yes |
| Vunjak-Novakovic13, 18 | 1 million | 12 | 6 cm Petri dish | PDMS posts with caps | optical deflection (edge detection) | yes | yes |
| Vunjak-Novakovic (MilliPillar)14 | 550 k | 6 | custom 6-well dish | PDMS posts with caps | optical deflection (object tracking); calcium imaging | no | yes |
| Eschenhagen (EHT)10, 19–21 | 1 million | 12 | 12-well plate | PDMS posts with caps | optical deflection (edge detection of post deflection); calcium imaging | no | yes |
| Zandstra (CaMiRi)22 | 25-150 k | 96 | 96-well plate | PDMS posts with hooks | optical deflection (edge detection) | no | yes |
| Murry23, 24 | 900 k | 24 | 24-well plate | PDMS posts with caps, integrated magnet | magnetic sensor | no | yes |
| Reich (µTUG)11, 12, 25 | undefined | 156 | 156-well dish | PDMS posts with caps, integrated magnet | optical tracking (fluorescent bead) | yes | yes |
Table 1: Characteristics of some linear engineered cardiac tissue models in the literature. Linear engineered cardiac tissue models vary in size, throughput, anchoring feature designs, and the facilitation of shared medium baths, as well as the requirements for a separate muscle bath system for functional characterization. * The researchers used a commercially available engineered tissue system based on the dimensions of a standard 6-well plate. ** A modular system in which single-tissue bioreactors are anchored to any plastic culture dish in the desired number and location.
This paper describes the latest protocol for fabricating our established model of linear human engineered cardiac tissue (hECT)1,2,3,4,5,6,7,8,9,15,27 and methods for assessing hECT contractile function. Each multi-tissue bioreactor accommodates up to six hECTs in a shared medium bath and is composed two "rack" pieces made of the silicone elastomer polydimethylsiloxane (PDMS) mounted on a rigid polysulfone frame. Each PDMS rack contains six flexible integrated force-sensing posts that are 0.5 mm in diameter and 3.25 mm long, and together, two racks provide six pairs of posts, each of which holds one hECT. Inversion of the bioreactor helps overcome any hindrance to the visualization of the hECTs from below due to water condensation from the culture medium or distortions from the meniscus of the air-liquid interface. Each contraction of an hECT causes deflection of the integrated end-posts, and the optical measurement of the deflection signal is processed into a force versus time tracing representing the contractile function of the hECT1,2,3,4,5,6,7,8,9,15,27. Compared to the single-tissue bioreactors typically used for tissues of this size, the multi-tissue design improves the experimental throughput and enables the study of paracrine signaling between adjacent tissues of potentially different cellular composition. This system has been validated in published studies describing applications in disease modeling4,8, paracrine signaling6,7, heterocellular culture5,9, and therapeutic screening7,9.
In this system, the hECTs are designed to be approximately 6 mm long and 0.5 mm in diameter to facilitate robust optical tracking of force measurements with low noise. Furthermore, aspects of tissue complexity such as diffusion gradients and cellular organization are balanced with a manageable requirement of 1 million cells per tissue. With standard CCD camera technology, forces as weak as 1 µN (representing less than 5 µm post deflection) generate a clear signal, ensuring that even extremely weak contractile function, as observed with some hECT disease models, can be accurately measured. This also facilitates the detailed analysis of the twitch force curve, thus enabling the high-content analysis of up to 16 contractility metrics41, including developed force, rates of contraction (+dF/dt) and relaxation (−dF/dt), and beat rate variability.
This protocol begins with instructions for fabricating the bioreactor components. Special attention is paid to the steps to maximize the hECT yield, reduce technical variability in the tissue function, and optimize the quality and depth of the tissue assessment. Most cardiac tissue engineering studies do not report rates of tissue loss during fabrication and long-term testing, although it is a well-known challenge in the field and reduces the throughput and efficiency of the studies27. The tissue engineering methods described here have been refined over the years to ensure retention of all hECTs in most of the bioreactors (regardless of how the PDMS racks are fabricated). However, even a 5%-20% loss of tissues can significantly affect the statistical power, particularly in smaller experiments limited by the number of cardiomyocytes available (e.g., due to differentiation challenges with some diseased cell lines4 or due to the high cost of commercially purchased cardiomyocytes), or by the treatment condition (e.g., limited availability or high cost of various treatment compounds).
This protocol describes the fabrication of stable post trackers (SPoTs), a new feature of the PDMS racks, which function as caps at the ends of the force-sensing posts that hold the hECTs27. It is demonstrated how the cap geometry significantly reduces the hECT loss from falling or pulling off the posts, thus opening new opportunities for culturing hECTs with a greater variety of stiffnesses and tensions, which are challenging to culture on uncapped posts. Additionally, the SPoTs provide a high-contrast object to improve the optical tracking of the hECT contraction through a consistent and well-defined shape27. This is followed by a description of culturing human induced pluripotent stem cells (iPSCs) and cardiomyocyte differentiation based on prior published protocols3,42,43 and an explanation of hECT fabrication, culture, and functional measurements.
This article also addresses the need to measure tissue function at physiological temperature. Human myocardium (fetal as well as adult healthy and diseased tissue), as well as heart tissue from a wide range of animal species (including rats, cats, mice, ferrets, and rabbits)44,45, displays a marked increase in the frequency-matched twitch force at temperatures of 28 °C-32 °C compared to physiological temperature-a phenomenon known as hypothermic inotropy45,46. However, the effects of temperature on engineered myocardial tissue function remain understudied. Many recent engineered cardiac tissue models in the literature are designed to be functionally assessed at 37 °C to approximate physiological conditions13,14,37. However, to our knowledge, the temperature-dependent effects on the force generated by engineered cardiac tissues have not been systematically investigated. This protocol describes a pacing electrode design that minimizes heat loss during testing, as well as allowing for the incorporation of an insulated heating element into the setup for functional measurements, which can maintain the hECTs at physiological temperature without compromising sterility27. We then report some of the observed effects of temperature on hECT function, including on the developed force, spontaneous beating frequency, +dF/dt, and −dF/dt. Altogether, this paper provides the details required to manufacture this multi-tissue force-sensing bioreactor system to fabricate human engineered cardiac tissues and to assess their contractile function, and a set of data is presented that provides a basis for comparison for measurements at room temperature and at 37 °C27.